cybiont operates under validation-driven engineering: architectural components are mapped to relevant Swiss and EU regulatory frameworks (FINMA, nDSG / GDPR, EU AI Act). The milestones below summarise public state.
Status
Completed (2025)
- Patent filings. Governance-layer IP filed with the Swiss IGE. Patent-pending. Additional IP related to inference-substrate engineering is handled only in controlled legal or technical diligence.
- Implementation validation. Internal builds of the governance substrate passed isolation-control and stress-test gates.
- Theoretical framework. Technical notes on knowledge systems (thermodynamic framing) published.
In progress (2025 Q4 — 2026)
- Performance profiling. Attestation latency and proof-aggregation throughput benchmarking.
- FINMA mapping. Detailed mapping of the cybiont architecture to FINMA Circular 2024/08 (risk-proportional AI-governance expectations).
- Independent security review. Third-party audit of isolation boundaries and key-handling controls.
Planned (2026)
- Controlled deployment in regulated environment. End-to-end deployment with a regulated-industry counterpart.
- EU AI Act assessment. Full assessment against Regulation (EU) 2024/1689 for high-risk systems (transparency, auditability, human oversight).
Regulatory frameworks
- FINMA. Swiss Financial Market Supervisory Authority. Engineered for Circular 2024/08 (risk-proportional AI governance) and Circular 2018/3 (outsourcing and supervisory oversight of externalised functions).
- Regulation (EU) 2024/1689 (EU AI Act). Readiness for high-risk-system requirements: transparency, auditability, human oversight, logging, traceability.
- nDSG (Swiss Federal Act on Data Protection, 2023) and GDPR (EU 2016/679). CH / EU data residency; client-held evidence and control.